The global oral proteins and peptides market reached a valuation of USD 1.8 Billion in 2024. According to IMARC Group, the market is projected to grow at a CAGR of 7.13% from 2025 to 2033, reaching USD 3.4 Billion by 2033. North America leads with over 97.8% market share in 2024. Growth is driven by advancements in drug delivery systems and a rising preference for non-invasive treatme... https://www.imarcgroup.com/oral-proteins-peptides-market